These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25453401)

  • 1. What is in the can? The dilemma with dietary supplements.
    D'Aco K; Mooney R; Cusmano-Ozog K; Hofherr S; Lichter-Konecki U
    Mol Genet Metab; 2014 Dec; 113(4):239-40. PubMed ID: 25453401
    [No Abstract]   [Full Text] [Related]  

  • 2. What gastroenterologists should know about the gray market, herbal remedies, and compounded pharmaceuticals and their regulation by the Food and Drug Administration.
    Ehrenpreis ED; Kulkarni P; Burke C;
    Am J Gastroenterol; 2013 May; 108(5):642-6. PubMed ID: 23644956
    [No Abstract]   [Full Text] [Related]  

  • 3. Compounding errors.
    Drazen JM; Curfman GD; Baden LR; Morrissey S
    N Engl J Med; 2012 Dec; 367(25):2436-7. PubMed ID: 23134355
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA inspections find unsafe practices in compounding pharmacies.
    McCarthy M
    BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
    [No Abstract]   [Full Text] [Related]  

  • 5. Compounding pharmacies: friend or foe.
    Springer R
    Plast Surg Nurs; 2013; 33(1):24-8. PubMed ID: 23446505
    [No Abstract]   [Full Text] [Related]  

  • 6. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 7. Compounding botanicals: a legal perspective.
    Valentino JG; Bormel FG
    J Am Pharm Assoc (Wash); 1999; 39(4):537-44. PubMed ID: 10467820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug compounding, drug safety, and the first amendment.
    Dresser R
    Hastings Cent Rep; 2013; 43(2):9-10. PubMed ID: 23494695
    [No Abstract]   [Full Text] [Related]  

  • 9. The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives.
    Blankenship C
    Int J Pharm Compd; 2018; 22(1):26-28. PubMed ID: 29385383
    [No Abstract]   [Full Text] [Related]  

  • 10. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating Compounding Pharmacies.
    Noble A
    NCSL Legisbrief; 2016 Nov; 24(42):1-2. PubMed ID: 27911513
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulators faulted for inadequate compounding pharmacy oversight.
    Traynor K
    Am J Health Syst Pharm; 2013 Jan; 70(1):8-10. PubMed ID: 23261891
    [No Abstract]   [Full Text] [Related]  

  • 13. Presence of banned drugs in dietary supplements following FDA recalls.
    Cohen PA; Maller G; DeSouza R; Neal-Kababick J
    JAMA; 2014 Oct 22-29; 312(16):1691-3. PubMed ID: 25335153
    [No Abstract]   [Full Text] [Related]  

  • 14. Compounding pharmacies: a viable option, or merely a liability?
    O'Brien D; Cohen I; Kennedy DJ
    PM R; 2013 Nov; 5(11):974-81. PubMed ID: 24247017
    [No Abstract]   [Full Text] [Related]  

  • 15. Bursting the analytical bubble.
    Czap A
    Altern Med Rev; 2004 Dec; 9(4):353-9. PubMed ID: 15675033
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulating compounding pharmacies after NECC.
    Outterson K
    N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
    [No Abstract]   [Full Text] [Related]  

  • 17. The "Lists": What Do They Mean?
    Voliva J
    Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
    [No Abstract]   [Full Text] [Related]  

  • 18. Atlas shrugged (kind of).
    Czap A
    Altern Med Rev; 2012 Mar; 17(1):1-4. PubMed ID: 22502617
    [No Abstract]   [Full Text] [Related]  

  • 19. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
    Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
    [No Abstract]   [Full Text] [Related]  

  • 20. Compounding pharmacies: before and after an inspection.
    Kulkarni D; Ricketts S
    Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.